Agata Villiger-Oberbek

Angestellt, Staff Scientist I, Sanofi

Greater Boston Area, Vereinigte Staaten

Fähigkeiten und Kenntnisse

Cell Line Engineering
High-Throughput Platform and Process Development
Chemically Defined Media Development
Protein Analysis
Molecular Biology
Lentiviral Vectors
Technical Writing
Scientific Conference Participation
Adobe Creative Suite

Werdegang

Berufserfahrung von Agata Villiger-Oberbek

  • Bis heute 10 Jahre und 2 Monate, seit Apr. 2014

    Staff Scientist I

    Sanofi

    Commercial Cell Culture Development

  • 6 Monate, Nov. 2013 - Apr. 2014

    Staff Scientist I

    Genzyme a Sanofi Company

    Development of chemically defined media formulations: high throughput, automated media blending; DoE guided component optimization; powder dissolution and manufacturability.

  • 2 Jahre und 2 Monate, Sep. 2011 - Okt. 2013

    Process Associate Scientist

    Genzyme a Sanofi Company

    Establishment of high throughput small scale cell culture platforms for commercial process development and bioreactor support. Development of chemically defined media.

  • 4 Jahre und 6 Monate, Mai 2006 - Okt. 2010

    PhD Candidate/Research Assistant

    EPFL

    Research and Teaching Assistant for Advanced Biotechnology Lab for Graduate Students; coresponsible for setting up and maintenance of a Biosafety level 2 facility.

  • 3 Monate, Feb. 2006 - Apr. 2006

    Research Intern

    Laboratory of Transcription Regulation, Nencki Institute of Experimental Biology

    Independent research project in the field of cancer neurobiology that initiated the group's studies toward the evaluation of several novel potential CK2 inhibitors as antitumor drugs against human gliomas.

  • 8 Monate, Okt. 2003 - Mai 2004

    Research Intern

    Biomedical Research Unit, University of Central Lancashire

    Part of a team investigating the potential of the breast cancer drug Tamoxifen against human glioblastomas using enzymatic and chemosensitivity tests in vitro.

Ausbildung von Agata Villiger-Oberbek

  • 4 Jahre und 6 Monate, Mai 2006 - Okt. 2010

    Biotechnology and Bioengineering

    EPFL

    Design, development, and characterization of a method for the rapid generation of stable manufacturing CHO cell lines using HIV-derived lentiviral vectors in serum-free suspension cultures without the addition of antibiotics or metabolic inhibitors.

  • 8 Monate, Okt. 2003 - Mai 2004

    Neuro-endocrino-oncology

    University of Central Lancashire

    One-year research exchange student at the Department of Biological Sciences; Completed master level courses with Merit (Upper Second Class Honors)

  • 1 Jahr und 11 Monate, Okt. 2003 - Aug. 2005

    Biology of Cell and Organism

    University of Warsaw

    Skeletal muscle regeneration

  • 2 Jahre und 10 Monate, Okt. 2000 - Juli 2003

    Biology of Cell and Organism

    University of Warsaw

Sprachen

  • Englisch

    Fließend

  • Französisch

    Fließend

  • Deutsch

    Grundlagen

  • Polnisch

    Muttersprache

21 Mio. XING Mitglieder, von A bis Z